NCT04413123
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04413123
Title Cabozantinib In Combo With NIVO + IPI In Advanced NCCRCC
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bradley A. McGregor
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02115 United States Details
Brigham & Woman's Hospital Boston Massachusetts 02115 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02115 United States Details
UT Southwestern Medical Dallas Texas 75390 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field